CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.38−0.47 (-25.41%)
Close on Nov 18, 2026Market cap $24.27MP/E –Yield –
Cel Sci gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Cel Sci
Cel Sci has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?